Related Experiment Videos

Arginine 304 is an active site residue in phosphomannose isomerase from Candida albicans

T N Wells1, P Scully, E Magnenat

  • 1Glaxo Institute for Molecular Biology, Geneva, Switzerland.

Biochemistry
|May 17, 1994
PubMed

Insights

Candida albicans phosphomannose isomerase (PMI) activity is inhibited by phenylglyoxal modification of arginine 304. Substrate protects the enzyme, indicating arginine 304

Area of Science:

  • Biochemistry
  • Enzymology
  • Protein Chemistry

Background:

  • Candida albicans phosphomannose isomerase (PMI) is crucial for mannose metabolism.
  • PMI exhibits bell-shaped pH dependence with pKa values at 5.6 and 8.7.

Purpose of the Study:

  • To investigate the mechanism of phenylglyoxal inhibition of Candida albicans PMI.
  • To identify the specific residue modified by phenylglyoxal and its role in enzyme activity.

Main Methods:

  • Enzyme kinetics and pH dependence studies.
  • Chemical modification with phenylglyoxal and substrate protection assays.
  • Radioactive labeling, peptide mapping, HPLC, and amino acid sequencing.

Main Results:

  • Phenylglyoxal inhibits PMI in a time-dependent manner, with a rate constant of 0.022 min-1 mM-1 at pH 8.5.
  • Mannose 6-phosphate protects PMI from phenylglyoxal inactivation, suggesting substrate-induced conformational changes.
  • Arginine 304 was identified as the sole residue modified by phenylglyoxal, leading to enzyme inactivation.

Conclusions:

  • Arginine 304 is critical for the catalytic activity of Candida albicans phosphomannose isomerase.
  • The modification of arginine 304 by phenylglyoxal provides insights into the enzyme's catalytic mechanism and active site structure.

Related Concept Videos